CytoMed Therapeutics Announces Financial Results for First Half of 2024, Provides Updates on Clinical Progress and Corporate Developments
Oct 1, 2024
Immunotherapy Investment Portfolios
CG Oncology Announces the Launch of Expanded Access Program for Key Immunotherapy Candidate
Jun 18, 2024
AIM ImmunoTech Commences Key Study for Pancreatic Cancer Treatment in Partnership with AstraZeneca
Feb 15, 2024
Kineta, Inc. Announces Participation in H.C. Wainwright Virtual Fireside Chat
Feb 7, 2024
TC BioPharm CEO Bryan Kobel Discusses Company's Future on 'The Big Biz Show'
Jan 30, 2024
Johnson & Johnson Acquires Ambrx Biopharma, Enhancing Cancer Drug Portfolio Amidst Harpoon Therapeutics Advancements
Jan 9, 2024